1,751 companies
ABPI
Accentia Biopharmaceuticals Inc
Accentia is a biotechnology company focused on discovering, developing and commercializing innovatative therapies that address the unmet medical needs of patients by utilizing therapeutic clinical products including personalized immunotherapies designed to treat autoimmune related diseases and cancer.
Florida
Inactive
OTC
ACUT
Accustem Sciences Inc.
AccuStem Sciences, Inc.(the “Company”) is a life sciences company focused on improving outcomes for patients with cancer.
New York
OTC
SLRN
Acelyrin Inc
ACELYRIN, INC. (Nasdaq: SLRN) is a Los Angeles area-based late-stage clinical biopharma company – with additional operations in the San Francisco Bay area – focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
California
NASDAQ
ACER
Acer Therapeutics Inc.
acer therapeutics is a biotech company, headquartered in cambridge, ma, that develops repurposed and reformulated medicines for the treatment of ultra-orphan diseases with significant unmet medical needs.
Massachusetts
NASDAQ
AKAOQ
Achaogen, Inc.
Achaogen, Inc.
California
NASDAQ
Achillion Pharmaceuticals Inc
We are a clinical-stage biopharmaceutical company focused on advancing our oral small molecule complement system inhibitors into late-stage development and commercialization. Each of the product candidates in our portfolio was discovered in our laboratories and is wholly owned by us. We are focusing our product development activities on complement-mediated diseases where there are no approved therapies or where significant unmet medical need persists despite existing therapies.
Connecticut
ACRS
Aclaris Therapeutics Inc
aclaris therapeutics, inc.
Pennsylvania
NASDAQ
Acologix, Inc.
California
Inactive
ACRV
Acrivon Therapeutics Inc
acrivon therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach.
Massachusetts
NASDAQ
RASP
Actavia Life Sciences, Inc.
Rasna Therapeutics, Inc.
New York
OTC
Actavis, Inc.
The investment seeks long-term capital appreciation.
The fund is an actively-managed exchange-traded fund that invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from tobacco and alcoholic beverages and companies that derive at least 50% of their net revenue from the marijuana and hemp industry or have at least 50% of their company assets dedicated to lawful research and development of cannabis or cannabinoid-related products.
New Jersey
ATNM
Actinium Pharmaceuticals Inc
actinium pharmaceuticals, inc.
New York
NYSEAMERICAN
HAQ
Activbiotics Inc
Massachusetts
Inactive
NASDAQ
Acucela Japan KK
Japan
Inactive
ACUR
Acura Pharmaceuticals, Inc
acura pharmaceuticals, inc.
Illinois
NASDAQ
ACXP
Acurx Pharmaceuticals Inc
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.
New York
NASDAQ
ACUS
Acusphere, Inc.
Acusphere, Inc.
Massachusetts
Inactive
OTC
ADAG
Adagene Inc
adagene was co-founded by two serial entrepreneurs to power antibody discovery.
China
NASDAQ
ADMS
Adamas Pharmaceuticals Inc
Adamas Pharmaceuticals Inc.
California
NASDAQ
ARXT
Adams Respiratory Therapeutics Inc
New Jersey
Inactive